HuGE Literature Finder
Records
1
-
1
SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1. Pancreas 0 47 (5): 637-642. Sato Yasunori, Ueno Hideki, Ioka Tatsuya, Ohkawa Shinichi, Ikeda Masafumi, Shimamura Tomotaka, Tsuji Akihito, Tsuchiya Yoshiaki, Furuse Junji, Ishii Hiroshi, Furuya Ken, Iguchi Haruo, Saito Yoshihiro, Kaniwa Nahoko, Sawada Jun-Ichi, Sakamoto Hiromi, Sekine Akihiro, Okusaka Takuji, Yoshida Teruhiko, |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 17, 2022
- Content source: